ZNF192 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.325600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
3.459600E-01
Normal-vs-Stage2
3.278400E-01
Normal-vs-Stage3
8.420000E-02
Normal-vs-Stage4
8.839400E-01
Stage1-vs-Stage2
2.294000E-01
Stage1-vs-Stage3
8.594300E-02
Stage1-vs-Stage4
3.587600E-01
Stage2-vs-Stage3
1.440760E-01
Stage2-vs-Stage4
8.920100E-03
Stage3-vs-Stage4
5.161600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.309000E-01
Normal-vs-AfricanAmerican
2.575800E-01
Normal-vs-Asian
3.672400E-02
Caucasian-vs-AfricanAmerican
5.675400E-01
Caucasian-vs-Asian
3.517000E-01
AfricanAmerican-vs-Asian
3.060800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.137600E-01
Normal-vs-Female
3.859800E-02
Male-vs-Female
2.256800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
2.834200E-01
Normal-vs-Age(41-60Yrs)
6.230500E-02
Normal-vs-Age(61-80Yrs)
3.146800E-01
Normal-vs-Age(81-100Yrs)
3.090200E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
6.982200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
9.163600E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
5.778400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
6.790300E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
9.134400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
3.557400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.865800E-01
Normal-vs-Daily Drinker
2.262000E-01
Normal-vs-Weekly Drinker
4.250100E-02
Normal-vs-Occasional Drinker
7.907700E-02
Normal-vs-Social Drinker
2.309200E-01
Non Drinker-vs-Daily Drinker
1.206790E-01
Non Drinker-vs-Weekly Drinker
7.417000E-01
Non Drinker-vs-Occasional Drinker
1.689240E-01
Non Drinker-vs-Social Drinker
1.164360E-01
Daily Drinker-vs-Weekly Drinker
1.212820E-01
Daily Drinker-vs-Occasional Drinker
1.165880E-02
Daily Drinker-vs-Social Drinker
1.823590E-02
Weekly Drinker-vs-Occasional Drinker
4.257000E-01
Weekly Drinker-vs-Social Drinker
2.372000E-01
Occasional Drinker-vs-Social Drinker
5.696600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.155200E-01
Normal-vs-Grade 2
4.594400E-02
Normal-vs-Grade 3
3.902200E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.684600E-01
Grade 1-vs-Grade 3
6.020200E-01
Grade 1-vs-Grade 4
1.155200E-01
Grade 2-vs-Grade 3
5.920600E-01
Grade 2-vs-Grade 4
4.594400E-02
Grade 3-vs-Grade 4
3.902200E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.214400E-01
Normal-vs-NonDiabetic
2.984600E-01
Diabetic-vs-NonDiabetic
5.835000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
2.677000E-01
Normal-vs-NoPancreatitis
3.152000E-01
Pancreatitis-vs-NoPancreatitis
3.781200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.512300E-02
Normal-vs-N1
3.315400E-01
N0-vs-N1
8.474000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
3.633600E-01
Normal-vs-TP53-NonMutant
4.579400E-01
TP53-Mutant-vs-TP53-NonMutant
1.501020E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
